Heather Brechbuhl
Concepts (153)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Breast Neoplasms | 10 | 2025 | 2253 | 1.700 |
Why?
| | Receptors, Estrogen | 6 | 2025 | 436 | 1.440 |
Why?
| | Cancer-Associated Fibroblasts | 2 | 2024 | 20 | 1.410 |
Why?
| | Receptors, Progesterone | 3 | 2024 | 350 | 1.030 |
Why?
| | Glutathione | 4 | 2011 | 356 | 0.890 |
Why?
| | Naphthalenes | 4 | 2014 | 60 | 0.830 |
Why?
| | Trachea | 3 | 2014 | 237 | 0.780 |
Why?
| | Neoplastic Cells, Circulating | 1 | 2020 | 80 | 0.640 |
Why?
| | ATP-Binding Cassette Transporters | 2 | 2010 | 137 | 0.600 |
Why?
| | Epithelial-Mesenchymal Transition | 1 | 2020 | 209 | 0.590 |
Why?
| | Leukocytes, Mononuclear | 1 | 2020 | 558 | 0.550 |
Why?
| | Biomarkers, Tumor | 3 | 2021 | 1276 | 0.540 |
Why?
| | Neoplasm Metastasis | 1 | 2020 | 658 | 0.540 |
Why?
| | Receptor, ErbB-2 | 2 | 2020 | 341 | 0.520 |
Why?
| | Neoplasm Proteins | 2 | 2010 | 434 | 0.510 |
Why?
| | CD146 Antigen | 3 | 2021 | 42 | 0.470 |
Why?
| | Stem Cells | 3 | 2014 | 594 | 0.460 |
Why?
| | src-Family Kinases | 1 | 2014 | 92 | 0.430 |
Why?
| | Respiratory Mucosa | 3 | 2014 | 321 | 0.430 |
Why?
| | Cell Lineage | 2 | 2011 | 350 | 0.380 |
Why?
| | Tumor Microenvironment | 4 | 2021 | 674 | 0.380 |
Why?
| | Cell Proliferation | 5 | 2025 | 2475 | 0.380 |
Why?
| | Estrogen Receptor alpha | 2 | 2025 | 145 | 0.380 |
Why?
| | MCF-7 Cells | 4 | 2025 | 124 | 0.380 |
Why?
| | Flavonoids | 1 | 2011 | 85 | 0.350 |
Why?
| | Proto-Oncogene Proteins | 1 | 2014 | 648 | 0.350 |
Why?
| | Antibiotics, Antineoplastic | 1 | 2011 | 127 | 0.340 |
Why?
| | Carrier Proteins | 2 | 2014 | 771 | 0.320 |
Why?
| | Doxorubicin | 1 | 2011 | 362 | 0.310 |
Why?
| | Prostaglandin D2 | 1 | 2009 | 23 | 0.310 |
Why?
| | Drug Resistance, Neoplasm | 3 | 2025 | 801 | 0.310 |
Why?
| | Gene Expression Regulation, Neoplastic | 6 | 2025 | 1396 | 0.310 |
Why?
| | beta Catenin | 1 | 2011 | 253 | 0.300 |
Why?
| | Adenosine Triphosphate | 1 | 2010 | 491 | 0.270 |
Why?
| | Tumor Cells, Cultured | 3 | 2020 | 955 | 0.260 |
Why?
| | Estrogens | 3 | 2018 | 367 | 0.250 |
Why?
| | Fatty Acid Synthase, Type I | 1 | 2025 | 11 | 0.230 |
Why?
| | Tamoxifen | 3 | 2025 | 202 | 0.210 |
Why?
| | Head and Neck Neoplasms | 1 | 2009 | 606 | 0.210 |
Why?
| | Cell Communication | 1 | 2024 | 315 | 0.190 |
Why?
| | Triglycerides | 1 | 2025 | 524 | 0.190 |
Why?
| | Epithelial Cells | 3 | 2014 | 1096 | 0.190 |
Why?
| | Aromatase Inhibitors | 1 | 2021 | 54 | 0.180 |
Why?
| | Estradiol | 1 | 2025 | 521 | 0.180 |
Why?
| | Lipid Metabolism | 1 | 2025 | 518 | 0.180 |
Why?
| | Cilia | 2 | 2014 | 178 | 0.180 |
Why?
| | Chromatin | 1 | 2025 | 519 | 0.170 |
Why?
| | Female | 11 | 2025 | 73304 | 0.170 |
Why?
| | Antineoplastic Agents, Hormonal | 2 | 2025 | 161 | 0.170 |
Why?
| | Cell Differentiation | 4 | 2014 | 1991 | 0.170 |
Why?
| | Cell Adhesion Molecules | 1 | 2021 | 181 | 0.170 |
Why?
| | Gene Expression Regulation | 1 | 2010 | 2607 | 0.170 |
Why?
| | Humans | 18 | 2025 | 137585 | 0.160 |
Why?
| | Cell Line, Tumor | 5 | 2025 | 3412 | 0.150 |
Why?
| | Antigens, Neoplasm | 1 | 2021 | 319 | 0.150 |
Why?
| | Neoadjuvant Therapy | 1 | 2021 | 404 | 0.150 |
Why?
| | Lung Neoplasms | 2 | 2011 | 2526 | 0.150 |
Why?
| | Neoplasm Invasiveness | 1 | 2020 | 510 | 0.140 |
Why?
| | Receptor, Fibroblast Growth Factor, Type 1 | 1 | 2018 | 53 | 0.140 |
Why?
| | Oligonucleotide Array Sequence Analysis | 2 | 2011 | 767 | 0.140 |
Why?
| | Mice, Transgenic | 2 | 2014 | 2167 | 0.140 |
Why?
| | RNA Polymerase III | 1 | 2017 | 28 | 0.140 |
Why?
| | Polyadenylation | 1 | 2017 | 42 | 0.130 |
Why?
| | Progestins | 1 | 2017 | 79 | 0.130 |
Why?
| | ErbB Receptors | 1 | 2020 | 614 | 0.130 |
Why?
| | Carcinogenesis | 1 | 2017 | 217 | 0.120 |
Why?
| | Mitochondrial Proteins | 1 | 2017 | 257 | 0.120 |
Why?
| | Animals | 7 | 2024 | 36940 | 0.110 |
Why?
| | Tyrphostins | 1 | 2014 | 18 | 0.110 |
Why?
| | Microtubule Proteins | 1 | 2014 | 16 | 0.110 |
Why?
| | Fibroblasts | 1 | 2020 | 996 | 0.110 |
Why?
| | Benzothiazoles | 1 | 2014 | 33 | 0.110 |
Why?
| | Regeneration | 2 | 2012 | 197 | 0.100 |
Why?
| | Quinazolines | 1 | 2014 | 251 | 0.100 |
Why?
| | Oxidative Stress | 2 | 2009 | 1317 | 0.100 |
Why?
| | Mice | 6 | 2018 | 17787 | 0.100 |
Why?
| | Prognosis | 1 | 2020 | 4030 | 0.090 |
Why?
| | beta-Galactosidase | 1 | 2011 | 78 | 0.090 |
Why?
| | Keratin-14 | 1 | 2010 | 15 | 0.090 |
Why?
| | Enzyme Inhibitors | 1 | 2014 | 840 | 0.090 |
Why?
| | Transgenes | 1 | 2011 | 180 | 0.080 |
Why?
| | Chalcones | 1 | 2010 | 7 | 0.080 |
Why?
| | Fluorescent Antibody Technique | 1 | 2011 | 390 | 0.080 |
Why?
| | tert-Butylhydroperoxide | 1 | 2009 | 10 | 0.080 |
Why?
| | Fungal Proteins | 1 | 2010 | 123 | 0.080 |
Why?
| | Nuclear Proteins | 1 | 2014 | 712 | 0.080 |
Why?
| | Chelating Agents | 1 | 2009 | 75 | 0.080 |
Why?
| | Cytoprotection | 1 | 2009 | 56 | 0.080 |
Why?
| | Mitochondrial Diseases | 1 | 2009 | 91 | 0.080 |
Why?
| | Biological Transport | 1 | 2010 | 418 | 0.080 |
Why?
| | Organometallic Compounds | 1 | 2009 | 111 | 0.070 |
Why?
| | Gene Expression Profiling | 2 | 2017 | 1774 | 0.070 |
Why?
| | Substrate Specificity | 1 | 2009 | 372 | 0.070 |
Why?
| | Blotting, Western | 1 | 2011 | 1226 | 0.070 |
Why?
| | Benzimidazoles | 1 | 2009 | 170 | 0.070 |
Why?
| | Chromatography, High Pressure Liquid | 1 | 2009 | 597 | 0.070 |
Why?
| | Amino Acids | 1 | 2010 | 497 | 0.060 |
Why?
| | Oxidation-Reduction | 1 | 2010 | 1060 | 0.060 |
Why?
| | Antioxidants | 1 | 2010 | 584 | 0.060 |
Why?
| | Saccharomyces cerevisiae | 1 | 2010 | 557 | 0.060 |
Why?
| | STAT1 Transcription Factor | 1 | 2025 | 72 | 0.060 |
Why?
| | Obesity | 1 | 2018 | 2992 | 0.060 |
Why?
| | Mice, Inbred C57BL | 2 | 2014 | 5757 | 0.050 |
Why?
| | Models, Biological | 1 | 2010 | 1783 | 0.050 |
Why?
| | Binding Sites | 1 | 2025 | 1303 | 0.050 |
Why?
| | Reactive Oxygen Species | 2 | 2017 | 622 | 0.040 |
Why?
| | Promoter Regions, Genetic | 1 | 2025 | 1250 | 0.040 |
Why?
| | Biomarkers | 1 | 2011 | 4149 | 0.040 |
Why?
| | Protein Binding | 1 | 2025 | 2224 | 0.040 |
Why?
| | Loss of Function Mutation | 1 | 2018 | 46 | 0.040 |
Why?
| | 3' Untranslated Regions | 1 | 2017 | 145 | 0.030 |
Why?
| | Mice, SCID | 1 | 2017 | 367 | 0.030 |
Why?
| | Lymphatic Metastasis | 1 | 2017 | 352 | 0.030 |
Why?
| | Disease-Free Survival | 1 | 2017 | 686 | 0.030 |
Why?
| | Mice, Inbred NOD | 1 | 2017 | 601 | 0.030 |
Why?
| | Weight Gain | 1 | 2018 | 519 | 0.030 |
Why?
| | Basal Bodies | 1 | 2014 | 16 | 0.030 |
Why?
| | Homeodomain Proteins | 1 | 2018 | 506 | 0.030 |
Why?
| | Mucociliary Clearance | 1 | 2014 | 45 | 0.030 |
Why?
| | Signal Transduction | 2 | 2018 | 5079 | 0.030 |
Why?
| | Centrioles | 1 | 2014 | 44 | 0.030 |
Why?
| | Xenograft Model Antitumor Assays | 1 | 2017 | 872 | 0.030 |
Why?
| | Amino Acid Motifs | 1 | 2014 | 225 | 0.030 |
Why?
| | rab GTP-Binding Proteins | 1 | 2014 | 75 | 0.030 |
Why?
| | Adipose Tissue | 1 | 2018 | 635 | 0.030 |
Why?
| | Protein Transport | 1 | 2014 | 445 | 0.020 |
Why?
| | RNA Interference | 1 | 2014 | 469 | 0.020 |
Why?
| | RNA, Small Interfering | 1 | 2014 | 622 | 0.020 |
Why?
| | Protein Structure, Tertiary | 1 | 2014 | 861 | 0.020 |
Why?
| | HEK293 Cells | 1 | 2014 | 730 | 0.020 |
Why?
| | Cell Membrane | 1 | 2014 | 738 | 0.020 |
Why?
| | Mitochondria | 1 | 2017 | 948 | 0.020 |
Why?
| | Disease Progression | 1 | 2018 | 2757 | 0.020 |
Why?
| | Diet | 1 | 2018 | 1278 | 0.020 |
Why?
| | Apoproteins | 1 | 2009 | 15 | 0.020 |
Why?
| | Heme Oxygenase-1 | 1 | 2009 | 64 | 0.020 |
Why?
| | Electron Transport | 1 | 2009 | 115 | 0.020 |
Why?
| | Electron Spin Resonance Spectroscopy | 1 | 2009 | 95 | 0.020 |
Why?
| | Copper | 1 | 2009 | 104 | 0.020 |
Why?
| | Bronchi | 1 | 2010 | 260 | 0.020 |
Why?
| | DNA, Mitochondrial | 1 | 2009 | 200 | 0.020 |
Why?
| | Apoptosis | 1 | 2017 | 2553 | 0.020 |
Why?
| | Hydrogen Peroxide | 1 | 2009 | 328 | 0.020 |
Why?
| | Reverse Transcriptase Polymerase Chain Reaction | 1 | 2009 | 976 | 0.020 |
Why?
| | Male | 1 | 2014 | 67762 | 0.020 |
Why?
| | Mice, Knockout | 1 | 2014 | 3015 | 0.020 |
Why?
| | Iron | 1 | 2009 | 313 | 0.020 |
Why?
| | DNA Damage | 1 | 2009 | 420 | 0.020 |
Why?
| | Cell Survival | 1 | 2009 | 1120 | 0.020 |
Why?
| | Flow Cytometry | 1 | 2009 | 1178 | 0.020 |
Why?
| | Cells, Cultured | 1 | 2010 | 4193 | 0.010 |
Why?
| | Phenotype | 1 | 2010 | 3196 | 0.010 |
Why?
| | Adult | 1 | 2017 | 37929 | 0.010 |
Why?
|
|
Brechbuhl's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors  People whose addresses are nearby this person. _
|